M. J. e Silva et al. / Carbohydrate Research 340 (2005) 309–314
313
H, 7.47. Found: C, 59.69; H, 7.72. The NMR spectra for
2b and 2c agreed with those of compounds 2a,b and 2c,d
above.
135.02 (C-900), 130.15 (C-700, C-1100), 127.95 (C-800, C-
1000), 101.71 (C-1), 76.51 (C-20), 71.98 (C-3), 70.72 (C-
4), 69.73 (C-2), 69.45 (C-5), 57.65 (C-200), 49.15 (C-500),
43.84 (C-10), 31.71 (C-300), 24.45 (C-400), 22.06 (C-30),
21.91(C-1200), 21.16 (COCH3), 21.07 (COCH3), 21.05
(COCH3), 16.59 (C-6). Anal. Calcd for C26H37NO10S:
C, 56.20; H, 6.71; N, 2.52; S, 5.77. Found: C, 56.20;
H, 7.01; N, 2.78; S, 5.85.
1.7. 1-Methyl-2-[N-(p-tolylsulfonyl)-2-pyrrolidinyl]ethyl
2,3,4-tri-O-acetyl-b-L-fucopyranoside (12a and 12b)
To a cold (À30 ꢁC) suspension of 2a,b (150 mg,
0.53 mmol) and trichloroacetimidate 11 (345 mg,
0.79 mmol) in dry CH2Cl2 (5.0 mL) containing a small
1.8. 1-Methyl-2-[N-(p-tolylsulfonyl)-2-pyrrolidinyl]ethyl
2,3,4-tri-O-acetyl-b-L-fucopyranoside (12b)
˚
amount of 4 A molecular sieves under argon atmosphere
was added TMSOTf (20 lL). After stirring for 1.5 h, the
reaction mixture was treated with 1.5 g of NaHCO3 and
filtered. Water was then added and the mixture was ex-
tracted with CH2Cl2 (3 · 20.0 mL). Drying (Na2SO4)
and solvent removal provided crude diastereoisomers
12a and 12b, which were separated by column chroma-
tography over silica gel using 1.5:1 petroleum ether–
EtOAc. The ratio of 12a (126.8 mg) and 12b (139 mg)
was ꢀ1:1. The combined yield was 91%.
To a cold (À5 ꢁC) suspension of 2b (20 mg, 0.07 mmol),
˚
trichloroacetimidate 11 (61 mg, 0.14 mmol) and 4 A
molecular sieves in dry CH2Cl2 (2.0 mL) under argon,
was added BF3ÆEt2O (20 lL). After stirring for 2 h, the
reaction mixture was treated with a satd aq NaHCO3
(4 mL) and filtered. Extraction of the mixture with
CH2Cl2 (3 · 20 mL), drying (Na2SO4) and solvent re-
moval provided the crude product of 12b, which was
purified by preparative TLC over silica gel using
9.7:0.3 toluene–MeOH to yield 30 mg (78%) of pure
12b. The NMR spectra agreed with those of compound
12b above.
Compound 12a: TLC (1.5:1.0 petroleum ether–
25
D
EtOAc): Rf 0.52; ½aꢁ +64.7 (c 1, CH2Cl2); mp 146–
1
147 ꢁC (petroleum ether–EtOAc); H NMR (300 MHz,
CDCl3): d 7.75 (d, 2H, J 8.2 Hz, H-700, H-1100), 7.34 (d,
2H, J 7.9 Hz, H-800, H-1000), 5.22 (d, 1H, J4,3 3.4 Hz,
H-4), 5.15 (dd, 1H, J2,1 7.7 Hz, J2,3 10.5 Hz, H-2), 5.04
(dd, 1H, J3,2 10.5 Hz, J3,4 3.4 Hz, H-3), 4.50 (d, 1H,
J1,2 7.7 Hz, H-1), 4.02–3.91 (m, 1H, H-20), 3.80–3.71
(m, 2H, H-200, H-5), 3.44–3.36 (m, 1H, H-500), 3.23–
3.15 (m, 1H, H-500), 2.43 (s, 3H, H-1200), 2.18 (s, 3H,
COCH3), 2.05 (s, 3H, COCH3), 1.99 (s, 3H, COCH3),
1.84–1.37 (m, 6H, H-300, H-400, H-10), 1.21 (d, 3H, J
6.0 Hz, H-30), 1.17 (d, 3H, J6,5 6.4 Hz, H-6); 13C NMR
(75.5 MHz, CDCl3): d 170.31 (CO), 169.87 (CO),
169.19 (CO), 142.78 (C-600), 134.20 (C-900), 129.21 (C-
700, C-1100), 127.37 (C-800, C-1000), 98.60 (C-1), 72.13 (C-
20), 71.06 (C-3), 70.05 (C-4), 68.71 (C-2), 68.60 (C-5),
56.94 (C-200), 48.66 (C-500), 42.76 (C-10), 30.72 (C-300),
23.50 (C-400), 21.16 (C-1200), 20.46 (COCH3), 20.39
1.9. 1-Methyl-2-[N-(p-tolylsulfonyl)-2-pyrrolidinyl]ethyl
b-L-fucopyranoside (1)
A 1% soln of 12 in 9:6:1 MeOH–water–triethylamine
was stirred overnight at room temperature. Water was
added and extraction with CH2Cl2 (3 · 20 mL), drying
(Na2SO4), filtration and solvent removal provided the
crude product 1. Column chromatography over silica
gel using 9.5:0.5 CH2Cl2–MeOH as eluent, gave pure
1, which after crystallization from 9:1 cyclohexane–
CH2Cl2, yielded colourless crystals.
25
D
Compound 1a: Starting from 12a, 91%; ½aꢁ +87.3 (c
0.48, MeOH); mp 196–198 ꢁC (C6H12–CH2Cl2); 1H
NMR (300 MHz, CD3OD): d 7.76 (d, 2H, J 8.1 Hz,
H-700, H-1100), 7.46 (d, 2H, J 7.8 Hz, H-800, H-1000), 4.22
(d, 1H, J1,2 7.8 Hz, H-1), 4.02–3.93 (m, 1H, H-20),
3.84–3.73 (m, 1H, H-200), 3.61–3.48 (m, 4H, H-2, H-3,
H-4, H-5), 3.38–3.07 (m, 2H, H-500), 2.43 (s, 3H, H-
1200), 2.21–2.12 (m, 1H, H-10), 1.78–1.32 (m, 5H, H-300,
H-400, H-10), 1.22 (d, 3H, J 6.0 Hz, H-30), 1.18 (d, 3H,
J6,5 6.6 Hz, H-6); 13C NMR (75.5 MHz, CD3OD): d
144.92 (C-600), 135.45 (C-900), 130.90 (C-700, C-1100),
128.94 (C-800, C-1000), 102.63 (C-1), 75.12 (C-20), 73.05
(C-3, C-4), 72.28 (C-2), 71.65 (C-5), 58.87 (C-200), 50.36
(C-500), 45.24 (C-10), 31.83 (C-300), 24.83 (C-400), 21.46
(C-1200), 20.79 (C-30), 16.85 (C-6). Anal. Calcd for
C20H31NO7S: C, 55.92; H, 7.27; N, 3.26; S, 7.46. Found:
(COCH3), 20.29 (COCH3), 19.23 (C-30), 15.17 (C-6);
+
HRFABMS[M+H] calcd for C26H38NO10S:
556.2217. Found = 556.2222.
Compound 12b: TLC (1.5:1 petroleum ether–EtOAc):
25
Rf 0.44; ½aꢁ À50 (c 1, CH2Cl2); mp 181–182 ꢁC (petro-
D
leum ether–EtOAc); 1H NMR (300 MHz, CDCl3): d
7.74 (d, 2H, J 8.2 Hz, H-700, H-1100), 7.36 (d, 2H, J
8.1 Hz, H-800, H-1000), 5.22 (d, 1H, J4,3 3.5 Hz, H-4),
5.18 (dd, 1H, J2,1 7.9, J2,3 10.3 Hz, H-2), 5.02 (dd, 1H,
J3,2 10.3, J3,4 3.5 Hz, H-3), 4.50 (d, 1H, J1,2 7.9 Hz, H-
1), 3.89 (m, 1H, H-20), 3.80 (m, 1H, H-5), 3.69 (m, 1H,
H-200), 3.41–3.33 (m, 1H, H-500), 3.26–3.18 (m, 1H, H-
500), 2.43 (s, 3H, H-1200), 2.17 (s, 3H, COCH3), 1.98 (s,
3H, COCH3), 1.91 (s, 3H, COCH3), 1.79–1.39 (m, 6H,
H-300, H-400, H-10), 1.36 (d, 3H, J 6.2 Hz, H-30), 1.23
(d, 3H, J6,5 6.2 Hz, H-6); 13C NMR (75.5 MHz, CDCl3):
d 171.20 (CO), 170.65 (CO), 169.65 (CO), 143.71 (C-600),
C, 55.99; H, 7.30; N, 3.29; S, 7.43.
25
D
Compound 1b: Starting from 12b, 88%; ½aꢁ À68.3 (c
0.36, MeOH); mp 171–172 ꢁC (C6H12–CH2Cl2); 1H
NMR (300 MHz, CDCl3): d 7.75 (d, 2H, J 8.4 Hz,